Pricing Log in Create free account

Cuprina Holdings (Cayman) Limited (CUPR) vs Femasys Inc. (FEMY)

Cuprina Holdings (Cayman) Limited and Femasys Inc. are both Medical Instruments & Supplies companies. Femasys Inc. is the larger, with a market value of $14.5M against $11.5M — 1.3× the size. Across the 5 metrics below, Cuprina Holdings (Cayman) Limited leads on 3 and Femasys Inc. on 2.

Valuation

Metric CUPR FEMY Medical Instruments & Supplies median
P/E — n/m 33.75
P/S — 2.41 2.52
P/B n/m 1.37 2.48
Price to free cash flow — n/m 25.19
EV/EBITDA n/m n/m 14.62
EV/Sales n/m 3.35 2.88
Earnings yield — (213.94%) (2.67%)
Free cash flow yield — (326.31%) 0.09%

Profitability

Metric CUPR FEMY Medical Instruments & Supplies median
Gross margin — 60.95% 54.29%
Operating margin — (763.90%) 1.07%
Net margin — (534.27%) (1.61%)
Free cash flow margin — (786.02%) 1.08%
Return on equity — (443.65%) (1.32%)
Return on assets — (94.25%) 0.00%
Return on invested capital 0.00% (176.91%) 0.00%

Growth

Metric CUPR FEMY Medical Instruments & Supplies median
Revenue growth (TTM) — 21.85% 8.85%
EPS growth (last fiscal year) (200.00%) 44.71% 8.65%
Revenue growth, 5-year CAGR — 17.18% 9.17%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CUPR FEMY Medical Instruments & Supplies median
Debt to equity 0.07 0.90 0.10
Current ratio 2.35 2.14 2.48
Net debt to EBITDA 0.57 0.23 0.89

Dividend

Metric CUPR FEMY Medical Instruments & Supplies median
Dividend yield — — 1.11%
Payout ratio — — 0.27

Size

Metric CUPR FEMY Medical Instruments & Supplies median
Market cap 11.48m 14.54m 619.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack